一个非典型的急性脑病症病例揭示了IgA多发性髓瘤
Jamie T Abad1, Tasnim Rahman1, Renieh Nabaty1
1Internal Medicine, Henry Ford Health System, Detroit, USA.
Cureus
|January 9, 2026
概括
多发性骨髓瘤 (MM) 可以出现不寻常的神经症状,如急性脑病变. 早期诊断和及时治疗,包括化疗,对于管理这种罕见但严重的并发症至关重要.
科学领域:
- 血液学 血液学 血液学
- 神经学 神经学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 通常具有潜伏的发病,可能会延迟诊断.
- 急性脑病是MM的罕见但严重的表现,复杂的识别和管理.
研究的目的:
- 突出MM作为无法解释的脑病变的原因.
- 为了强调MM的神经表现的复杂性.
主要方法:
- 一个57岁的MM妇女的病例介绍,呈现出脑病变.
- 诊断工作包括骨活检,实验室测试 (类蛋白,氨) 和脑部MRI.
- 治疗包括血合成,类固醇和基于博特佐米布的化疗.
主要成果:
- 患者表现出疲劳,背部疼痛,跌倒,体重减轻,高血症,贫血,功能障碍和骨损伤.
- 她的病情进展为严重的脑病变,对最初的治疗没有反应.
- 在启动基于博尔特佐米布的化疗后,获得了神经改善.
结论:
- 在无法解释的脑病变的情况下,应该考虑MM.
- 及时的血液学评估和跨学科管理对于MM的复杂神经学表现至关重要.
更多相关视频
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
14.5K
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.9K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
